Literature DB >> 2154763

Characterization of [3H] (+)-pentazocine, a highly selective sigma ligand.

W D Bowen1, B DeCosta, S B Hellewell, A Thurkauf, J M Walker, K C Rice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2154763

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  7 in total

1.  (+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord.

Authors:  Leon F Tseng; Quinn H Hogan; Hsiang-En Wu
Journal:  Life Sci       Date:  2011-10-02       Impact factor: 5.037

2.  Ethanol-related behaviors in mice lacking the sigma-1 receptor.

Authors:  Marta Valenza; Alyssa DiLeo; Luca Steardo; Pietro Cottone; Valentina Sabino
Journal:  Behav Brain Res       Date:  2015-10-14       Impact factor: 3.332

3.  Sigma binding in a human neuroblastoma cell line.

Authors:  J Ryan-Moro; C C Chien; K M Standifer; G W Pasternak
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

4.  Pharmacological comparison of the sigma recognition site labelled by [3H]haloperidol in human and rat cerebellum.

Authors:  J M Barnes; N M Barnes; P C Barber; S Champaneria; B Costall; C D Hornsby; J W Ironside; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

Review 5.  Effects of opioids, cannabinoids, and vanilloids on body temperature.

Authors:  Scott M Rawls; Khalid Benamar
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

6.  Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer.

Authors:  John R Hornick; Suwanna Vangveravong; Dirk Spitzer; Carmen Abate; Francesco Berardi; Peter Goedegebuure; Robert H Mach; William G Hawkins
Journal:  J Exp Clin Cancer Res       Date:  2012-05-02

7.  The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.

Authors:  John R Hornick; Jinbin Xu; Suwanna Vangveravong; Zhude Tu; Jonathan B Mitchem; Dirk Spitzer; Peter Goedegebuure; Robert H Mach; William G Hawkins
Journal:  Mol Cancer       Date:  2010-11-22       Impact factor: 27.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.